Khosla Ventures Acquisition (KVSA): Price and Financial Metrics
GET POWR RATINGS... FREE!
KVSA Stock Price Chart Interactive Chart >
KVSA Price/Volume Stats
|Current price||$9.81||52-week high||$10.01|
|Prev. close||$9.80||52-week low||$9.58|
|Day high||$9.82||Avg. volume||106,211|
|50-day MA||$9.80||Dividend yield||N/A|
|200-day MA||$9.77||Market Cap||348.16M|
Khosla Ventures Acquisition (KVSA) Company Bio
Khosla Ventures Acquisition is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.
Most Popular Stories View All
KVSA Latest News Stream
|Loading, please wait...|
KVSA Latest Social Stream
View Full KVSA Social Stream
Latest KVSA News From Around the Web
Below are the latest news stories about KHOSLA VENTURES ACQUISITION CO that investors may wish to consider to help them evaluate KVSA as an investment opportunity.
The billionaire investor says he invests for the longterm and doesn't pay much attention to the ups and downs of the market.
Investment company Westchester Capital Funds (Current Portfolio) buys Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Kensington Capital Acquisition Corp V, Isos Acquisition Corp, sells , Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Reinvent Technology Partners Y during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Westchester Capital Funds.
Khosla and Boston-based Valo Health gave “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, which was announced in June.
Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement
Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process and Khosla Ventures Acquisition Co. (Nasdaq: KVSA) ("KVSA"), a special purpose acquisition company sponsored by affiliates of Khosla Ventures, LLC, announced today that both companies have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), ef
Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. (Nasdaq: KVSA) ("KVSA"), a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC ("Khosla Ventures"), today announced that the private placement of common stock ("PIPE") investment in connection with their previously announced business combination
KVSA Price Returns